Brief: Island Pharmaceuticals Says Galidesivir Approved For Treatment Use In Ebola Epidemic
07/07/2026 02:43
BRIEF-Island Pharmaceuticals Says Galidesivir Approved For Treatment Use In Ebola Epidemic July 7 (Reuters) - Island Pharmaceuticals Ltd ILA.AX:
GALIDESIVIR APPROVED FOR TREATMENT USE IN IN EBOLA EPIDEMIC
GALIDESIVIR TO BE DEPLOYED WITHIN CY26
SECURES ALL APPROVALS FOR COMPASSIONATE USE OF GALIDESIVIR IN BUNDIBUGYO EBOLA EPIDEMIC
Further company coverage: ILA.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Island Pharmaceuticals
See all newsBrief: Island Pharmaceuticals Says Pivotal Marburg Data Secured For Galidesivir FDA Pathway
Brief: Island Pharmaceuticals Posts Prelim FY Loss Attributable Of A$9.8 Million
Australia's Island Pharmaceuticals rises as company boosts Galidesivir production
Brief: Island Pharmaceuticals Boosts Galidesivir Supply As Ebola Surges
Island Pharmaceuticals hits seven-month high on Galidesivir approval for Ebola epidemic